Detalles de la búsqueda
1.
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report.
Int J Hyperthermia
; 37(1): 55-65, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918587
2.
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Breast Cancer Res
; 21(1): 60, 2019 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077239
3.
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.
Int J Cancer
; 145(6): 1538-1546, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30801698
4.
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
BMC Med
; 16(1): 179, 2018 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301470
5.
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.
Mod Pathol
; 31(4): 607-615, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29271415
6.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
Lancet Oncol
; 15(7): 747-56, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24794243
7.
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer.
Breast Cancer Res Treat
; 143(3): 493-505, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24402830
8.
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Tumour Biol
; 34(1): 81-90, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22983919
9.
Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer.
Int J Hyperthermia
; 29(1): 8-16, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23245336
10.
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.
NPJ Breast Cancer
; 9(1): 23, 2023 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029138
11.
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
Eur J Cancer
; 181: 155-165, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657324
12.
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.
Immunology
; 137(3): 226-38, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23025755
13.
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Lancet Oncol
; 11(6): 561-70, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20434400
14.
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
Breast Care (Basel)
; 16(2): 173-180, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012372
15.
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 145: 44-52, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423006
16.
Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study.
Front Pharmacol
; 10: 410, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133847
17.
Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
Clin Breast Cancer
; 18(6): e1323-e1337, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100104
18.
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma.
Oncotarget
; 9(32): 22741-22748, 2018 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29854312
19.
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
JAMA Oncol
; 4(4): 483-492, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29450452
20.
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial.
Oncotarget
; 8(46): 80156-80166, 2017 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29113291